Validation of Aprataxin as a biomarker of response to Topoisomerase I inhibitors in cancer patients VALPRAXIN
| Short Name | Funding Agency | Expedient | Institute | Year |
|---|---|---|---|---|
| VALPRAXIN | Instituto de Salud Carlos III | ERANET TRANSCAN-VALPRAXIN | 2012 |
 |
 |
 |
 |
| Short Name | Funding Agency | Expedient | Institute | Year |
|---|---|---|---|---|
| VALPRAXIN | Instituto de Salud Carlos III | ERANET TRANSCAN-VALPRAXIN | 2012 |
|
|
|
|